关于心力衰竭的当代审查,改善了喷射分数
Allison Weiss1, Ambre Flowers1, Scott D Eisenberg1
1Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA.
NPJ cardiovascular health
|March 3, 2026
概括
改善射出分数 (HF-iEF) 的心力衰竭意味着更好的预后. 这篇评论详细介绍了HF-iEF的细节.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心力衰竭 (HF) 是一种复杂的临床综合征,具有不同的病因,影响心脏输出和压力.
- 左心室喷射分数 (LVEF) 是HF分类中的一个关键的预后指标.
- 治疗方法,设备和二次原因管理方面的进步改善了HF的结果.
研究的目的:
- 定义和探索心力衰竭的特征与改善的射出分数 (HF-iEF).
- 审查HF-iEF的临床意义和预后影响.
- 概述HF-iEF患者目前的管理策略.
主要方法:
- 最近研究的文献综述和临床指南.
- 分析与心力衰竭患者的LVEF变化相关的预后数据.
- 对HF-iEF的治疗方法的证据综合.
主要成果:
- 改善喷射分数 (HF-iEF) 的心力衰竭被确定为一个独特的临床实体.
- 与持续低LVEF患者相比,HF-iEF患者的预后更为有利.
- 特定的病因和临床轨迹与LVEF改善有关.
结论:
- HF-iEF代表了心力衰竭患者的重要亚组,其结果得到了改善.
- 了解HF-iEF的定义,原因和临床意义对于定制管理至关重要.
- 对优化HF-iEF治疗的进一步研究是有必要的.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.


